BackCaliPharms Overview

CaliPharms Other Assets

Track CaliPharms's other assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

CaliPharms Other Assets History

Loading

CaliPharms vs. peers: Other Assets Comparison

Loading

CaliPharms Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CaliPharms (KGET) FAQ

The latest other assets for KGET is $0 as of September 2014. In the prior-year period, the figure was $0. Investors often review this figure alongside CaliPharms's historical trend and sector peers before judging valuation or financial health.

Over the past year, KGET's other assets moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CaliPharms's operating scale or balance-sheet position.

A other assets figure of $0 for KGET is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting KGET's other assets ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack CaliPharms's other assets against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.